U.S. Genome Editing Market Size, Share & Trends Analysis Report By Technology (CRISPR, ZFN), By Delivery Method (Ex-vivo, In-vivo), By Mode (Contract, In-house), By Application, By End-use, And Segment Forecasts, 2024 - 2030

Market Segmentation

• U.S. Genome Editing Technology Outlook (Revenue, USD Million, 2018 - 2030)
  • Meganucleases
  • (CRISPR)/Cas9
  • TALENs/MegaTALs
  • ZFN
  • Others
• U.S. Genome Editing Delivery Method Outlook (Revenue, USD Million, 2018 - 2030)
  • Ex-vivo
  • In-vivo
• U.S. Genome Editing Mode Outlook (Revenue, USD Million, 2018 - 2030)
  • Contract
  • In-house
• U.S. Genome Editing Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Genetic Engineering
  • Cell Line Engineering
  • Animal Genetic Engineering
  • Plant Genetic Engineering
  • Others
  • Clinical Applications
  • Diagnostics
  • Therapy Development
• U.S. Genome Editing End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Biotechnology & Pharmaceutical Companies
  • Academic & Government Research Institutes
  • Contract Research Organizations

Report content

Qualitative Analysis

• Industry overview
• Industry trends
• Market drivers and restraints
• Market size
• Growth prospects
• Porter’s analysis
• PESTEL analysis
• Key market opportunities prioritized
• Competitive landscape
  • Company overview
  • Financial performance
  • Product benchmarking
  • Latest strategic developments

Quantitative Analysis

• Market size, estimates, and forecast from 2018 to 2030
• Market estimates and forecast for product segments up to 2030
• Country market size and forecast for product segments up to 2030
• Market estimates and forecast for application segments up to 2030
• Country market size and forecast for application segments up to 2030
• Company financial performance